Jefferies Downgrades Prothena Corporation (PRTA) After Negative Trial Results

finance.yahoo.com/news/jefferies-downgrades-prothena-corporation-prta-170843785.html

In This Article:
On May 27, Jefferies downgraded Prothena Corporation plc (NASDAQ:PRTA) to Hold from Buy and slashed the price target to $6 from $32.
The considerable price target reduction followed the company's announcement regarding the discontinuation of its Phase 3 AFFIRM-AL…

This story appeared on finance.yahoo.com, 2025-05-27 17:08:43.
The Entire Business World on a Single Page. Free to Use →